In this study, we reported on the design of a multiplex real-time PCR assay based on SYBR Green I, incorporating dual priming adenine-thymine (AT)-rich primers for direct detection of MRSA from nasal samples. The multiplex real-time polymerase chain reaction (RT-PCR) assay reported in this study is based on SYBR Green I with incorporation of six dual priming AT-rich primers designed from the SCCmec/orf junction. A string (4-6 bp) of low-melting bases, such as adenine and thymine, was incorporated into the primers, which virtually divided a single primer in two functional regions, thus decreasing non-specific PCR products. The analytical sensitivity and specificity of the RT-PCR assay was determined with genomic DNA of reference strains (MRSA, MSSA, and MRCoNS). RT-PCR assay was performed for analysis of 72 nasal swab specimens, and the results were confirmed by use of a culture method. Furthermore, the results of RT-PCR were compared with LightCycler MRSA advance test. The multiplex RT-PCR assay reproducibly detected a minimum of 1 pg genomic DNA (31.5 copy of genome) of MRSA reference strains and clinical isolates, with a specific melting peak at 83.5 ± 1.5°C, and neither fluorescence nor a melting peak was detected in non-target isolates. The concordance rate between RT-PCR assay and culture method was 87.5% with Cohen's kappa value (κ) 0.75, which showed good agreement between the two assays. The sensitivity, specificity, positive predictive value, and negative predictive value of the assay were 93.5%, 82.9%, 80.5%, and 94.4%, respectively. In a comparative study for the detection of 72 nasal samples, the sensitivity, specificity, positive predictive value, and negative predictive value of the multiplex RT-PCR assay with respect to LightCycler MRSA advance test was 84.2%, 88.2%, 89%, and, 83.3%, respectively. The results of RT-PCR assay demonstrated high specificity (88.2%) and positive predictive value (89%) for the direct detection of MRSA from nasal samples.

Department of Otorhinolaryngology Head and Neck Surgery Dongguk University Ilsan Hospital Goyang Gyeonggi South Korea

Zobrazit více v PubMed

J Clin Microbiol. 2010 Oct;48(10):3525-31 PubMed

Nucleic Acids Res. 2007;35(6):e40 PubMed

J Clin Microbiol. 2008 Oct;46(10):3285-90 PubMed

Antimicrob Agents Chemother. 2001 May;45(5):1323-36 PubMed

J Clin Microbiol. 2010 Apr;48(4):1305-9 PubMed

Antimicrob Agents Chemother. 2002 Jul;46(7):2155-61 PubMed

Clin Microbiol Infect. 2005 Oct;11(10):834-7 PubMed

J Clin Microbiol. 2009 Nov;47(11):3769-72 PubMed

Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S65-71 PubMed

Euro Surveill. 2009 Dec 10;14(49): PubMed

PCR Methods Appl. 1993 May;2(4):346-7 PubMed

J Clin Microbiol. 2010 Dec;48(12):4612-4 PubMed

Nucleic Acids Res. 1997 Dec 15;25(24):4876-82 PubMed

Clin Infect Dis. 2003 Jan 1;36(1):53-9 PubMed

J Clin Microbiol. 2005 Nov;43(11):5536-40 PubMed

Antimicrob Agents Chemother. 2004 Jul;48(7):2637-51 PubMed

J Clin Microbiol. 2008 May;46(5):1577-87 PubMed

Antimicrob Agents Chemother. 2008 Oct;52(10):3512-6 PubMed

J Clin Microbiol. 2004 May;42(5):1875-84 PubMed

Ann Clin Lab Sci. 2008 Summer;38(3):254-7 PubMed

Helicobacter. 2009 Feb;14(1):22-8 PubMed

Diagn Microbiol Infect Dis. 2005 Jan;51(1):13-7 PubMed

Eur J Clin Microbiol Infect Dis. 2009 Jan;28(1):47-53 PubMed

J Clin Microbiol. 2010 Mar;48(3):720-7 PubMed

Lancet. 2001 Apr 21;357(9264):1225-40 PubMed

J Clin Microbiol. 2008 Jan;46(1):350-1 PubMed

J Microbiol Methods. 2007 Jan;68(1):157-62 PubMed

Antimicrob Agents Chemother. 2007 Dec;51(12):4342-50 PubMed

J Clin Microbiol. 2008 Feb;46(2):743-6 PubMed

Clin Microbiol Infect. 2007 Jul;13(7):725-7 PubMed

Antimicrob Agents Chemother. 2009 Feb;53(2):531-40 PubMed

Diagn Microbiol Infect Dis. 2006 Sep;56(1):13-8 PubMed